Argonautica Private Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Argonautica Private Wealth Management's NVS Position: Q2 2026 in Review
Argonautica Private Wealth Management sold out of Novartis (NVS) in Q2 2026, closing a stake of 5,416 shares — an estimated $827K sold.
Argonautica Private Wealth Management first reported a position in NVS in Q4 2022 and held it in 14 quarters. The position peaked at $827K in Q1 2026. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Argonautica Private Wealth Management reported no remaining Novartis position as of Q2 2026 after selling out during the quarter.
- Argonautica Private Wealth Management sold 5,416 Novartis shares in Q2 2026, an estimated $827K.
- Argonautica Private Wealth Management first reported a position in Novartis in Q4 2022 and held it in 14 quarters.
- Argonautica Private Wealth Management's Novartis position peaked at $827K in Q1 2026.
- 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Argonautica Private Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.